cannabinoid Downloads
7 downloads found
Our potent and selective hCB2 cannabinoids receptor fluorescent ligand shows high affinity for hCB2 cannabinoids receptor and selectivity over hCB1 (Ki =75.9 nM for hCB2 receptor in radioligand binding assay). It is suitable for HTRF binding assays as a valid alternative to radioligand binding assays. It allows to perform cell visualization in fluorescence microscopy, confocal and high content ...
ByCeltarys
Our potent hCB cannabinoids receptors fluorescent ligand shows high affinity for hCB1/CB2 cannabinoids receptor (Ki =44.8 nM and 7.4 nM , respectively in radioligand binding assay). It has been validated in High Content Screening assays and it is suitable also for HTRF binding assays as a valid alternative to radioligand binding assays. It allows to perform cell visualization in fluorescence ...
ByCeltarys
CanaQuest Medical Corp. (CANQF) is a clinical-stage life sciences company that specializes in developing innovative cannabinoid-based therapeutics. The company's primary focus is on CQ-001, a proprietary drug candidate that combines cannabidiol (CBD) with essential fatty acids (Omega-3s). Prior research and animal studies have demonstrated CQ-001's synergistic effects and enhanced ability to bind ...
A Clinical Stage/Life Sciences company focussed on the drug discovery and development of next generation targeted therapeutics within the endocannabinoid system and specific brain receptors. Partnered for industry research and product development with Dr. Steven Laviolette, a professor and neuroscientist, with decades of experience in the field of mental health and cannabinoids, at Western ...
Vision: To be the Global Leader in Cannabinoid Therapeutics. A Clinical Stage/Life Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and related targets. Partnered with world-leadingorganizations in research, clinical trials and commercialization with expertise in neuroscience and ...
CanaQuest Medical is an award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder “PTSD,” including ...